{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:05:20Z","timestamp":1791201920460,"version":"4.2.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.pharmthera.2004.02.001","type":"journal-article","created":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T10:20:36Z","timestamp":1080642036000},"page":"47-60","source":"Crossref","is-referenced-by-count":97,"title":["New insights into the mechanisms of antidepressant therapy"],"prefix":"10.1016","volume":"102","author":[{"given":"Patrick","family":"Schloss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz A.","family":"Henn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2004.02.001_BIB1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.1990.tb16875.x","article-title":"Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms","volume":"600","author":"Aghajanian","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(94)90386-7","article-title":"C\/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia","volume":"76","author":"Alberini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB3","first-page":"59","article-title":"Neurotrophins and depression","volume":"20","author":"Altar","year":"1999","journal-title":"TIPS"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/1097-4547(20000701)61:1<82::AID-JNR10>3.0.CO;2-E","article-title":"Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation","volume":"61","author":"Anthony","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB5","first-page":"744","article-title":"Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins","volume":"287","author":"Apparsundaram","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archpsyc.1994.03950030084009","article-title":"Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors","volume":"51","author":"Artigas","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB7","first-page":"378","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"TINS"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00171317","article-title":"Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo","volume":"352","author":"Auerbach","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB9","first-page":"539","article-title":"Effect of chronic antidepressant or electroconvulsive shock treatment on mGLuR1a immunoreactivity expression in the rat hippocampus","volume":"51","author":"Bajkowska","year":"1999","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB10","doi-asserted-by":"crossref","first-page":"26219","DOI":"10.1074\/jbc.272.42.26219","article-title":"Interaction of phosphorylated tryptophan hydroxylase with 14-3-3 proteins","volume":"272","author":"Banik","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB12","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1523\/JNEUROSCI.19-23-10494.1999","article-title":"Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level","volume":"19","author":"Benmansour","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB13","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1523\/JNEUROSCI.22-15-06766.2002","article-title":"Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter","volume":"22","author":"Benmansour","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB11","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1046\/j.1471-4159.2003.01792.x","article-title":"Role of protein phosphatase 2C from bovine adrenal chromaffin cells in the dephosphorylation of phospho-serine 40 tyrosine hydroxylase","volume":"85","author":"Bevilaqua","year":"2003","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pharmthera.2004.02.001_BIB14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(88)91453-9","article-title":"Regionally selective increases in beta-adrenergic receptor density in the brains of suicide victims","volume":"442","author":"Biegon","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-3223(98)00124-3","article-title":"Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins","volume":"44","author":"Blakely","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004714-199506000-00011","article-title":"Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression","volume":"15","author":"Blier","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB17","first-page":"220","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"TIPS"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB18","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1460-9568.1996.tb01336.x","article-title":"Inhibition of N-type calcium channels: the only mechanism by which presynaptic alpha 2-autoreceptors control sympathetic transmitter release","volume":"8","author":"Boehm","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1054-3589(08)60723-1","article-title":"Role of protein kinase C and second messengers in regulation of the norepinephrine transporter","volume":"42","author":"Bonisch","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB20","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.1074\/jbc.270.16.9197","article-title":"Antipeptide antibodies confirm the topology of the human norepinephrine transporter","volume":"270","author":"Br\u00fcss","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1006\/bbrc.1998.9158","article-title":"Possible existence of quaternary structure in the high-affinity serotonin transport complex","volume":"249","author":"Chang","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl. 14","key":"10.1016\/j.pharmthera.2004.02.001_BIB21","first-page":"11","article-title":"Monoamine dysfunction and the pathophysiology and treatment of depression","volume":"59","author":"Charney","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB23","series-title":"Neurotransmitter Transporters. Structure, Function and Regulation","first-page":"27","article-title":"Structure-function relationships for biogenic amine neurotransmitter transporters","author":"Chen","year":"2002"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB152","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.npp.1300289","article-title":"Downregulation of the CCAAT-enhancer binding protein beta in deltaFosB transgenic mice and by electroconvulsive seizures","volume":"29","author":"Chen","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB24","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","article-title":"Depression and diabetes: impact of depressive symptoms on adherence, function and costs","volume":"160","author":"Ciechanowski","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB25","doi-asserted-by":"crossref","first-page":"14695","DOI":"10.1074\/jbc.272.23.14695","article-title":"Analysis of the transmembrane topology and membrane assembly of the GAT-1 gamma-aminobutyric acid transporter","volume":"272","author":"Clark","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB27","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1523\/JNEUROSCI.22-08-03262.2002","article-title":"CREB is essential for the upregulation of BDNF transcription, but not the behavioural or endocrine responses to antidepressant drugs","volume":"22","author":"Conti","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","article-title":"The biochemistry of affective disorders","volume":"113","author":"Coppen","year":"1967","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1176\/ajp.150.5.720","article-title":"The enduring psychosocial consequences of mania and depression","volume":"150","author":"Coryell","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0896-6273(03)00195-8","article-title":"Finding the intracellular signaling pathways affected by mood disorder treatments","volume":"38","author":"Coyle","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-3223(99)00014-1","article-title":"Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action","volume":"46","author":"Delgado","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0028-3908(84)90095-9","article-title":"Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment","volume":"23","author":"de Montigny","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB33","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1176\/ajp.151.9.1312","article-title":"Suicidality in patients with pure and depressive mania","volume":"151","author":"Disalver","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB34","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(05)79827-5","article-title":"Increased temporal cortex CREB concentrations and antidepressant treatment in major depression","volume":"352","author":"Dowlatshahi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB35","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0024-3205(00)00530-0","article-title":"Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine","volume":"66","author":"Dreshfield-Ahmad","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB36","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.mp.4001016","article-title":"Synaptic plasticity and mood disorders","volume":"7","author":"Duman","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00124509-199809000-00004","article-title":"Molecular and cellular actions of chronic electroconvulsive seizures","volume":"14","author":"Duman","year":"1998","journal-title":"J ECT"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","article-title":"Neural plasticity to stress and antidepressant treatment","volume":"46","author":"Duman","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB39","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1471-4159.1991.tb02054.x","article-title":"Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression","volume":"56","author":"Edwards","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB40","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1471-4159.1989.tb07272.x","article-title":"Formal demonstration of the phosphorylation of rat brain tryptophan hydroxylase by Ca2+\/calmodulin-dependent protein kinase","volume":"52","author":"Ehret","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00261435","article-title":"\u03b12-Autoreceptors and \u03b12-heteroreceptors modulating tyrosine and tryptophan hydroxylases in vivo: an investigation into the \u03b12-adrenoceptors subtypes","volume":"353","author":"Esteban","year":"1996","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002109900045","article-title":"Activation and desensitization by cyclic antidepressant drugs of \u03b12-autoreceptors, \u03b12-heteroreceptors and 5-HT1A autoreceptors regulating monoamine synthesis in the rat brain in vivo","volume":"360","author":"Esteban","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0193-953X(05)70291-4","article-title":"The management of treatment-resistant depression in the medically ill","volume":"19","author":"Franco-Bronson","year":"1996","journal-title":"Psychiatry Clin N Am"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB44","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1006\/mcne.2000.0841","article-title":"Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype","volume":"15","author":"Galter","year":"2000","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1476-5381.1986.tb11171.x","article-title":"Activation and desensitization of presynaptic a2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens","volume":"89","author":"Garcia-Sevilla","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB46","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1471-4159.2003.01944.x","article-title":"Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promotor-linked polymorphic region","volume":"86","author":"Glatz","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB47","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1975955","article-title":"Cloning and expression of a rat brain GABA transporter","volume":"249","author":"Guastella","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-8993(02)03193-1","article-title":"Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus","volume":"952","author":"Gur","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB49","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1073\/pnas.181344298","article-title":"Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment","volume":"98","author":"Hastrup","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0166-2236(02)02144-6","article-title":"Location, location, location: a spatial view of neurotrophin signal transduction","volume":"25","author":"Heerssen","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB51","first-page":"152","article-title":"Animal models of depression","volume":"1","author":"Henn","year":"1993","journal-title":"Clin Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB52","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0024-3205(02)02482-7","article-title":"Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration","volume":"72","author":"Hensler","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB53","first-page":"131","article-title":"A quantitative autoradiographic study of serotonin1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments","volume":"4","author":"Hensler","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00179315","article-title":"The 5-HT1A agonist 8-OH-DPAT preferentially activates cell body 5-HT autoreceptors in rat brain in vivo","volume":"338","author":"Hiorth","year":"1988","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB55","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB56","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1523\/JNEUROSCI.14-07-04318.1994","article-title":"Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics","volume":"14","author":"Hope","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB57","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/00001756-200107200-00027","article-title":"Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor","volume":"12","author":"Horschitz","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB58","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1471-4159.2003.01899.x","article-title":"Functional coupling of serotonin and norepinephrine transporters","volume":"86","author":"Horschitz","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1471-4159.1997.68010225.x","article-title":"Porbol esters increase dopamine transporter phosphorylation and decrease transport Vmax","volume":"68","author":"Huff","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/bj3110353","article-title":"Structure and function of the aromatic amino acid hydroxylases","volume":"311","author":"Hufton","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB61","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.mp.4000728","article-title":"Neurotransmitter transporters: fruitful targets for CNS drug discovery","volume":"5","author":"Iversen","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0014-5793(96)00916-7","article-title":"The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein","volume":"394","author":"Jess","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB63","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1471-4159.1995.65020882.x","article-title":"Tryptophan hydroxylase is phosphorylated by protein kinase A","volume":"65","author":"Johansen","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB64","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1038\/sj.mp.4001017","article-title":"Mood stabilizers, glycogen synthase kinase-3\u03b2 and cell survival","volume":"7","author":"Jope","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB66","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.060408997","article-title":"Oligomerization of serotonin transporter and its functional consequences","volume":"97","author":"Kilic","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB65","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/mol.61.4.778","article-title":"Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline","volume":"61","author":"Kim","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0922-4106(94)90180-5","article-title":"Phorbol esters alter functions of the expressed dopamine transporter","volume":"268","author":"Kitayama","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB68","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0006-3223(96)00502-1","article-title":"Long-term stress degenerates, but imipramine regenerates noradrenergic axons in the rat cerebral cortex","volume":"42","author":"Kitayama","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB153","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/clinchem\/34.5.807","article-title":"The changing epidemiology of depression","volume":"34","author":"Klerman","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB69","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1046\/j.1471-4159.2003.01793.x","article-title":"Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters","volume":"85","author":"Kocabas","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3956(02)00056-0","article-title":"Changes in CREB-phosphorylation during recovery from major depression","volume":"36","author":"Koch","year":"2002","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB71","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0006-3223(97)00345-4","article-title":"The serotonin transporter messenger RNA level in rat brain is not regulated by antidepressants","volume":"42","author":"Koed","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0169-328X(98)00130-2","article-title":"Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein 43, and microtubule-associated protein 2 mRNA expression in rat hippocampus","volume":"59","author":"Kuroda","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(00)03287-X","article-title":"Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus","volume":"893","author":"Lamont","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0028-3908(90)90047-U","article-title":"Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT","volume":"29","author":"Larsson","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0169-328X(93)90069-2","article-title":"Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants","volume":"17","author":"Lesch","year":"1993","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB76","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1460-9568.2002.01901.x","article-title":"Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain","volume":"15","author":"Lindgren","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB77","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(99)00126-2","article-title":"Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade","volume":"46","author":"Linner","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB78","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990\u20132020","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB79","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-3223(94)91262-9","article-title":"Serotonin transporter mRNA in rat brain is regulated by classical antidepressants","volume":"35","author":"Lopez","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB80","doi-asserted-by":"crossref","first-page":"15239","DOI":"10.1073\/pnas.96.26.15239","article-title":"Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities","volume":"96","author":"Lyons","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB84","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/sj.npp.1300234","article-title":"Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment","volume":"28","author":"Malberg","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB85","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in the hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB86","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1523\/JNEUROSCI.15-12-07929.1995","article-title":"Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain","volume":"15","author":"Mamounas","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB87","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1523\/JNEUROSCI.20-02-00771.2000","article-title":"BDNF promotes the regenerative sprouting, but not survival of injured serotonergic axons in the adult rat brain","volume":"10","author":"Mamounas","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/NMM:1:3:197","article-title":"5HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells","volume":"1","author":"Meller","year":"2002","journal-title":"Neuromol Med"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB91","series-title":"The serotonin hypothesis of depression. Psychopharmacology","author":"Meltzer","year":"1987"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB89","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(79)92838-1","article-title":"Abnormal 24 hour pattern of melatonin secretion in depression","volume":"2","author":"Mendlewicz","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0005-2736(94)90051-5","article-title":"The in situ size of the dopamine transporter is a tetramer as estimated by radiation inactivation","volume":"1190","author":"Milner","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB94","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archpsyc.55.7.580","article-title":"The relationship of depression to cardiovascular diseases: epidemiology, biology and treatment","volume":"55","author":"Musselman","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB96","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0092-8674(91)90504-R","article-title":"A naturally occurring truncated form of FosB that inhibits Fos\/Jun transcriptional activity","volume":"64","author":"Nakabeppu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB97","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1523\/JNEUROSCI.22-22-09868.2002","article-title":"Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus","volume":"22","author":"Nakagawa","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB98","first-page":"517","article-title":"Psychopharmacology of affective disorders in the 21st century","volume":"44","author":"Nemeroff","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0893-133X(96)00095-4","article-title":"Chronic fluoxetine reduce serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus","volume":"15","author":"Neumaier","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB101","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB102","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB103","first-page":"425","article-title":"Electroconvulsive therapy","volume":"vol. 3","author":"Nobler","year":"2001"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB104","first-page":"250","article-title":"Neuropharmacological aspects of ECT: in search of the primary mechanism of action","volume":"5","author":"Nutt","year":"1989","journal-title":"Convuls Ther"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0168-0102(94)90041-8","article-title":"Phorbol ester-induced inhibition of GABA uptake by synaptosomes and by Xenopus oocytes expressing GABA transporter (GAT1)","volume":"19","author":"Osawa","year":"1994","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB106","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/350350a0","article-title":"Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter","volume":"350","author":"Pacholczyck","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB107","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF00164579","article-title":"Alpha 2-autoreceptor-mediated modulation of tyrosine hydroxylases activity in noradrenergic regions of the rat brain in vivo","volume":"345","author":"Pi","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB108","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1523\/JNEUROSCI.14-05-03036.1994","article-title":"Desensitization of the neuronal 5-HT carrier following its long-term blockade","volume":"14","author":"Pineyro","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB109","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000056185","article-title":"Desensitization of alpha(2)-adrenoceptors which regulate noradrenaline synthesis and release after chronic treatment with clorgyline in the rat brain","volume":"65","author":"Prieto","year":"2002","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1523\/JNEUROSCI.17-01-00045.1997","article-title":"Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression","volume":"17","author":"Quian","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB111","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A","article-title":"Somato-dendritic localization of 5-HT1A and preterminal localization of 5-HT1B serotonin receptors in adult rat brain","volume":"417","author":"Riad","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB112","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1471-4159.2002.01264.x","article-title":"Up-regulation of the serotoninergic phenotype in vitro: BDNF and camp share TrkB-dependent mechanisms","volume":"83","author":"Rumajogee","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB113","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s002100000334","article-title":"Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors","volume":"363","author":"Sacchetti","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB114","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Increased cortical GABA concentrations in depressed patients receiving ECT","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2004.02.001_BIB116","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0006-8993(01)02190-4","article-title":"Relationships between beta- and alpha2-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide","volume":"898","author":"Sastre","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB117","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1046\/j.1471-4159.1995.65051967.x","article-title":"Modulation of the recombinant rat glycine transporter GLYT1b by protein kinase C","volume":"65","author":"Sato","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB118","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(95)01191-G","article-title":"The recombinant GABA transporter GAT1 is down-regulated upon activation of protein kinase C","volume":"375","author":"Sato","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB119","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/026988119801200201","article-title":"The serotonin transporter: a primary target for antidepressant drugs","volume":"12","author":"Schloss","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0955-0674(94)90081-7","article-title":"Neurotransmitter transporters: new members of known families","volume":"6","author":"Schloss","year":"1994","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB121","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1074\/jbc.M007357200","article-title":"Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells","volume":"276","author":"Schmid","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1471-4159.1989.tb07319.x","article-title":"In vivo measurement of brain extracellular 5-hydroxytryptamine using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity","volume":"53","author":"Sharp","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1476-5381.1989.tb11815.x","article-title":"5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis","volume":"96","author":"Sharp","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB127","first-page":"317","article-title":"Pharmacotherapy of affective disorders","volume":"vol. 3","author":"Shergill","year":"2001"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB123","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain derived neurotrophic factor produces antidepressant effects in behavioural models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1097-4547(19980415)52:2<149::AID-JNR3>3.0.CO;2-A","article-title":"BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain","volume":"52","author":"Siuciak","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB129","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotropic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2007-979192","article-title":"Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement","volume":"32","author":"Stassen","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB131","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00702-002-0732-5","article-title":"Evidence for involvement of protein kinases in the regulation of serotonin synthesis and turnover in the mouse brain in vivo","volume":"109","author":"Stenfors","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB134","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1176\/ajp.153.5.674","article-title":"Suicidality among patients with mixed and manic bipolar disorder","volume":"153","author":"Strakowski","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB133","doi-asserted-by":"crossref","first-page":"47653","DOI":"10.1074\/jbc.M208755200","article-title":"Phosphorylation-induced conformational changes in a mitogen-activated protein kinase substrate. Implications for tyrosine hydroxylase activation","volume":"277","author":"Stultz","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0006-8993(93)91281-V","article-title":"Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment","volume":"618","author":"Szot","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB136","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/90520","article-title":"The consolidation of new but not reactivated memory requires hippocampal C\/EBPbeta","volume":"4","author":"Taubenfeld","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB137","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.270.5236.593","article-title":"Neurotrophins and neuronal plasticity","volume":"270","author":"Thoenen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB154","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1523\/JNEUROSCI.20-11-04030.2000","article-title":"cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment","volume":"20","author":"Thome","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB138","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0140-6736(90)92202-S","article-title":"Seasonal affective disorder and season-dependent abnormalities of melatonin suppression by light","volume":"360","author":"Thompson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB139","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1046\/j.1471-4159.1997.69052019.x","article-title":"Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies","volume":"69","author":"Trillat","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB140","doi-asserted-by":"crossref","first-page":"21262","DOI":"10.1074\/jbc.M007520200","article-title":"Autoregulation of cell-specific MAP kinase control of the tryptophan hydroxylase promotor","volume":"276","author":"Wood","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB141","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1046\/j.1471-4159.2000.0741961.x","article-title":"Regulation of tryptophan hydroxylase activity in Xenopus laevis photoreceptor cells by cyclic AMP","volume":"74","author":"Valenciano","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB143","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0306-4522(98)00289-9","article-title":"Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures","volume":"89","author":"Vaidya","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB144","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1523\/JNEUROSCI.06-12-03474.1986","article-title":"Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats","volume":"6","author":"Verg\u00e9","year":"1986","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB145","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.mp.4000907","article-title":"Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness","volume":"6","author":"Vollmayr","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0006-3223(03)00527-4","article-title":"Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness","volume":"54","author":"Vollmayr","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB146","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(01)00158-9","article-title":"Chronic and acute regulation of Na+\/Cl\u2212 dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signalling systems","volume":"92","author":"Zahniser","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB147","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1004632206684","article-title":"Functional impairment and cognition in bipolar disorder","volume":"71","author":"Zarate","year":"2000","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB148","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0361-9230(99)00063-5","article-title":"Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells","volume":"49","author":"Zavosh","year":"1999","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB149","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1471-4159.1997.68010134.x","article-title":"Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors","volume":"68","author":"Zhu","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB150","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1046\/j.1471-4159.1998.70041547.x","article-title":"Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine","volume":"70","author":"Zhu","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2004.02.001_BIB151","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1471-4159.2002.00953.x","article-title":"Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue","volume":"82","author":"Zhu","year":"2002","journal-title":"J Neurochem"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580400021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580400021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T05:53:28Z","timestamp":1682661208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372580400021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S016372580400021X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2004.02.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}